BioCentury This Week

Ep. 304 - Syncona Reshapes Fund; Lilly's $1B Verve Bet; FDA's 2-Track Future


Listen Later

Publicly traded U.K. investment firm and company builder Syncona is restructuring its fund amid ongoing market challenges in the biopharma industry. On the latest BioCentury This Week podcast, BioCentury’s analysts discuss how the firm will steer its portfolio toward returns for shareholders, while aiming to build a new fund away from public markets. The analysts then assess Eli Lilly's takeout of cardiovascular base editing company Verve, and what Washington Editor Steve Usdin calls FDA’s new “two-track” future for evaluating new therapies for approval — those with clear-cut benefits and those with ambiguous efficacy safety and efficacy profiles — in light of the many departures of senior FDA staff. They also discuss NASDAQ’s largest biopharma IPO — by Caris —  in two years, the latest obesity readouts, FDA Commissioner Marty Makary’s priority pathway and Usdin’s Q&A with new BIO Chair Fritz Bittenbender. This episode of BioCentury This Week was sponsored by ICON Biotech.

View full story: https://www.biocentury.com/article/656266

#biotech #biopharma #pharma #lifescience #finance #CV #FDA

00:01 - Sponsor Message: ICON Biotech
02:14 - Syncona Restructures Fund
10:08 - Lilly's $1B Verve Takeout
21:45 - FDA's 2-Track Future

To submit a question to BioCentury’s editors, email the BioCentury This Week team at [email protected].

Reach us by sending a text

...more
View all episodesView all episodes
Download on the App Store

BioCentury This WeekBy BioCentury

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

28 ratings


More shows like BioCentury This Week

View all
Nature Podcast by Springer Nature Limited

Nature Podcast

752 Listeners

Masters in Business by Bloomberg

Masters in Business

2,173 Listeners

The Bio Report by Levine Media Group

The Bio Report

39 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

122 Listeners

The Readout Loud by STAT

The Readout Loud

318 Listeners

Biotech 2050 Podcast by Biotech 2050

Biotech 2050 Podcast

59 Listeners

Business Of Biotech by Ben Comer

Business Of Biotech

88 Listeners

Raising Health by Andreessen Horowitz, a16z Bio + Health

Raising Health

147 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

10 Listeners

Cell & Gene: The Podcast by Erin Harris

Cell & Gene: The Podcast

38 Listeners

The Big Take by Bloomberg

The Big Take

155 Listeners

Beyond Biotech - the podcast from Labiotech by Labiotech

Beyond Biotech - the podcast from Labiotech

3 Listeners

The Top Line by Fierce Life Sciences

The Top Line

11 Listeners

Ground Truths by Eric Topol

Ground Truths

51 Listeners

The BioCentury Show by BioCentury

The BioCentury Show

11 Listeners